Skip to main content
pCPA File Number:
20745
Negotiation Status:
Concluded with an LOI
Indication(s):
Hereditary Angioedema
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CDA-AMC Project Number:
SR0375-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: